Paclitaxel / AXL Cancer Research Results

PacT, Paclitaxel: Click to Expand ⟱

Features:

Paclitaxel (brand name Taxol) is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. Administered by intravenous injection.
Derived from a natural product, Taxol (from Pacific Yew Tree).
Paclitaxel is a drug (chemotherapy; a taxane). Its dominant anticancer mechanism is microtubule stabilization, which disrupts normal mitosis and drives mitotic arrest/stress signaling that can culminate in apoptosis.

Paclitaxel – Cancer Pathway Matrix

Rank	Pathway / Axis	Cancer / Tumor Context	Normal Tissue Context	TSF	Primary Effect	Notes / Interpretation
1	Microtubule stabilization → Mitotic arrest	Mitotic progression ↓; spindle dynamics impaired; cell division blocked	Proliferating normal cells affected	R, G	Core cytotoxic mechanism	Binds β-tubulin and stabilizes microtubules, preventing normal depolymerization required for mitosis.
2	Spindle assembly checkpoint activation	Prolonged mitotic arrest → mitotic catastrophe or apoptosis	Checkpoint stress in dividing tissues	R, G	Mitotic stress execution	Cell fate depends on whether arrest resolves via apoptosis or mitotic slippage.
3	Intrinsic apoptosis (mitochondrial pathway)	Caspase activation ↑; BAX/mitochondrial signaling engaged (context)	Limited unless stressed	G	Cell death execution	Often downstream of prolonged mitotic stress and mitochondrial perturbation.
4	ROS generation (secondary)	ROS ↑ (context-dependent); oxidative stress amplification	Oxidative stress possible in sensitive tissues	R, G	Stress amplifier	ROS rise appears secondary to mitotic and mitochondrial dysfunction; may enhance apoptosis.
5	Nrf2 antioxidant response (adaptive)	Nrf2 ↑ in some tumors; antioxidant buffering ↑; resistance potential	Protective antioxidant signaling	G	Adaptive resistance axis	Not a direct paclitaxel target; elevated Nrf2 may reduce drug sensitivity.
6	Drug resistance mechanisms	P-glycoprotein (MDR1) ↑; β-tubulin alterations; survival rewiring	—	G	Treatment failure driver	Efflux pumps and tubulin adaptations are major clinical resistance mechanisms.
7	Myelosuppression	—	Neutropenia risk ↑	G	Dose-limiting toxicity	Bone marrow suppression is a primary clinical constraint.
8	Peripheral neuropathy	—	Sensory neuropathy risk ↑	G	Dose-limiting toxicity	Likely related to microtubule disruption in axonal transport.

Time-Scale Flag (TSF):
P = 0–30 min (drug binding begins)
R = 30 min–3 hr (mitotic stress signaling, ROS changes)
G = >3 hr (apoptosis, resistance adaptation, tissue toxicities)

AXL, Anexelekto: Click to Expand ⟱

Source:

Type:

AXL (Anexelekto) is a receptor tyrosine kinase that plays a crucial role in the regulation of cell growth, survival, and migration.
AXL is involved in the regulation of cell growth and survival, and its overexpression has been linked to the development of cancer.
AXL works by binding to its ligand, growth arrest-specific protein 6 (GAS6), which activates the AXL receptor and triggers a signaling cascade that promotes cell growth and survival.
AXL can also interact with other proteins, including PI3K and AKT, to regulate cell growth and survival.

Scientific Papers found: Click to Expand⟱

577-

Api,

PacT,

Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells

in-vitro,

Ovarian,

SKOV3

40uM

p‑Akt↓, Bcl-xL↓, Bcl-2↓, AXL↓, Tyro3↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Cell Death ⓘ

p‑Akt↓, 1, Bcl-2↓, 1, Bcl-xL↓, 1,

Migration ⓘ

AXL↓, 1, Tyro3↓, 1,
Total Targets: 5

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: AXL, Anexelekto

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells